Plasma oxidized LDL: a predictor for acute myocardial infarction?
- 21 March 2003
- journal article
- Published by Wiley in Journal of Internal Medicine
- Vol. 253 (4), 425-429
- https://doi.org/10.1046/j.1365-2796.2003.01128.x
Abstract
Oxidized LDL has been attributed a key role in the development of atherosclerosis. Previous studies have demonstrated increased plasma levels of oxidized LDL in patients with established coronary artery disease. The aim of the present study was to investigate if plasma oxidized LDL also predicts risk for development of coronary heart disease (CHD). We used a nested case-control design to study the association between plasma levels of oxidized LDL and risk for development of acute myocardial infarction (AMI) and/or death by CHD. Oxidized LDL was analysed by ELISA in cases (n = 26), controls (n = 26) and controls with LDL cholesterol >5.0 mmol L-1 (n = 26). Oxidized LDL correlated with total plasma and LDL cholesterol in both cases (r = 0.72, P < 0.01, r = 0.69, P < 0.01, respectively) and controls (r = 0.71, P < 0.01, r = 0.77, P < 0.01, respectively). The oxidized LDL/plasma cholesterol ratio was higher amongst cases (13.5, range 10.7-19.8) than in controls (12.6, range 9.5-15.8, P < 0.05) and hypercholesterolaemic controls (12.2, range 8.0-16.0, P < 0.01). These findings identify high plasma oxidized LDL/total cholesterol ratio as a possible indicator of increased risk for AMI.Keywords
This publication has 12 references indexed in Scilit:
- Circulating Oxidized LDL Is a Useful Marker for Identifying Patients With Coronary Artery DiseaseArteriosclerosis, Thrombosis, and Vascular Biology, 2001
- Elevated Levels of Oxidized Low Density Lipoprotein Show a Positive Relationship With the Severity of Acute Coronary SyndromesCirculation, 2001
- Low-Dose Metoprolol CR/XL and Fluvastatin Slow Progression of Carotid Intima-Media ThicknessCirculation, 2001
- AtherosclerosisCell, 2001
- Relation between insulin resistance and carotid intima‐media thickness and stenosis in non‐diabetic subjects. Results from a cross‐sectional study in Malmö, SwedenDiabetic Medicine, 2000
- Oxidized LDL and Malondialdehyde-Modified LDL in Patients With Acute Coronary Syndromes and Stable Coronary Artery DiseaseCirculation, 1998
- Oxidized Low Density Lipoproteins in Patients With Transplant-Associated Coronary Artery DiseaseArteriosclerosis, Thrombosis, and Vascular Biology, 1998
- Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy MenNew England Journal of Medicine, 1997
- Heterogeneity of plasma low-density lipoproteins and atherosclerosis riskCurrent Opinion in Lipidology, 1994
- Susceptibility to low-density lipoprotein oxidation and coronary atherosclerosis in manThe Lancet, 1992